Page last updated: 2024-10-22

aminoglutethimide and Diabetes Insipidus

aminoglutethimide has been researched along with Diabetes Insipidus in 1 studies

Aminoglutethimide: An aromatase inhibitor that is used in the treatment of advanced BREAST CANCER.
aminoglutethimide : A dicarboximide that is a six-membered cyclic compound having ethyl and 4-aminophenyl substituents at the 3-position.

Diabetes Insipidus: A disease that is characterized by frequent urination, excretion of large amounts of dilute URINE, and excessive THIRST. Etiologies of diabetes insipidus include deficiency of antidiuretic hormone (also known as ADH or VASOPRESSIN) secreted by the NEUROHYPOPHYSIS, impaired KIDNEY response to ADH, and impaired hypothalamic regulation of thirst.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Torres-Zamora, M1
López-Uriarte, A1
Lisci-Garmilla, A1
González-Bárcena, D1
Ramírez-Rodríguez, C1

Other Studies

1 other study available for aminoglutethimide and Diabetes Insipidus

ArticleYear
[Effects of alpha-aminoglutethimide administration in a patient with pituitary diabetes insipidus].
    Archivos de investigacion medica, 1972, Volume: 3, Issue:3

    Topics: Administration, Oral; Adult; Aminoglutethimide; Cortisone; Diabetes Insipidus; Diuresis; Glucocortic

1972